Is the generalizability of a developed artificial intelligence algorithm for COVID-19 on chest CT sufficient for clinical use? Results from the International Consortium for COVID-19 Imaging AI (ICOVAI) - Takeaways - MDSpire

Is the generalizability of a developed artificial intelligence algorithm for COVID-19 on chest CT sufficient for clinical use? Results from the International Consortium for COVID-19 Imaging AI (ICOVAI)

  • By

  • Laurens Topff

  • Kevin B. W. Groot Lipman

  • Frederic Guffens

  • Rianne Wittenberg

  • Annemarieke Bartels-Rutten

  • Gerben van Veenendaal

  • Mirco Hess

  • Kay Lamerigts

  • Joris Wakkie

  • Erik Ranschaert

  • Stefano Trebeschi

  • Jacob J. Visser

  • Regina G. H. Beets-Tan

  • January 18, 2023

  • 0 min

Share

  • 1

    The ICOVAI consortium developed an AI model for COVID-19 segmentation and CO-RADS classification using a multicenter dataset of 1286 chest CT scans.

  • 2

    Automated segmentation of lung abnormalities can enhance clinical workflow by providing timely quantitative analysis and CO-RADS classification.

  • 3

    External validation of AI models is crucial, as only 22% of reviewed studies on COVID-19 imaging completed this step, raising concerns about generalizability.

  • 4

    The study included a diverse cohort, with 375 CT scans used for external validation, ensuring a robust evaluation of the AI model's performance.

  • 5

    The ICOVAI model aims to improve diagnostic accuracy and efficiency in interpreting chest CT scans for COVID-19, addressing labor-intensive manual processes.

Original Source(s)

Related Content